NVCR — NovoCure Ltd
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1645113 ·
Jersey
Last close
$14.22
Market Cap
$1.66B
52W High
$21.45
52W Low
$9.82
ADV30
1,255,276
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 183,584,000 | 142,478,000 | -10,562,000 | -15,658,000 | 795,191,000 | 93,701,000 | 457,099,000 |
| Mar 2026 | 174,055,000 | 135,126,000 | -67,420,000 | -71,138,000 | 787,926,000 | 87,527,000 | 457,209,000 |
| Dec 2025 | 174,350,000 | 132,193,000 | -40,393,000 | -24,499,000 | 804,326,000 | 93,548,000 | 463,860,000 |
| Sep 2025 | 167,204,000 | 122,475,000 | -36,021,000 | -37,270,000 | 1,361,194,000 | 342,119,000 | 1,019,861,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-26,883,000
Investing CF
$451,495,000
Financing CF
$-456,756,000
CapEx
$-21,189,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.53
As of
2026-07-26
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,361,495,000
Inventory
$43,458,000
Receivables
$146,404,000
ST Investments
$344,477,000
EBIT TTM
$-148,768,000
Pretax Income TTM
$-175,213,000
Interest Exp TTM
—
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$699,193,024
EBITDA
$-136,392,992
Free Cash Flow
$22,763,750
Enterprise Value
$1,598,935,936
Total Cash
$440,559,008
Total Debt
$233,420,000
Shares Out
116,445,840
Trailing EPS
$-1.30
Book Value
$2.90
ROE
-43.2%
ROA
-9.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 655,353,000 | -153,800,000 | -136,227,000 | 804,326,000 | 463,860,000 | 340,466,000 | -49,031,000 |
| Dec 2024 | 605,220,000 | -170,496,000 | -168,627,000 | 1,240,784,000 | 880,605,000 | 360,179,000 | -26,369,000 |
| Dec 2023 | 509,338,000 | -232,870,000 | -207,043,000 | 1,146,129,000 | 783,633,000 | 362,496,000 | -73,336,000 |
| Dec 2022 | 537,840,000 | -89,523,000 | -92,534,000 | 1,191,648,000 | 750,478,000 | 441,170,000 | 30,788,000 |
TTM Snapshot
Revenues TTM
$674,414,000
NetIncome TTM
$-173,046,000
OpCashFlow TTM
—
Assets (Latest)
$787,926,000
Forward EPS
$-0.82
Max Pain — expiry 2027-01-15
max pain strike: $13.00 · spot: $14.22 · call oi: 11,301 · put oi: 535
Expected Move to 2027-01-15:
±$12.05
(84.74%) —
implied range
$2.17 –
$26.27
· ATM straddle on $14.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ATEC | Alphatec Holdings, Inc. | $1.60B | $10.35 | — |
| XRAY | DENTSPLY SIRONA Inc. | $1.73B | $8.69 | — |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | $1.81B | $60.61 | — |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $1.51B | $25.77 | — |
| LMAT | LEMAITRE VASCULAR INC | $1.82B | $79.64 | — |
News headlines (Yahoo Finance, 1h cache)
Novocure’s Optune Pax® Receives Approval in Japan for the Treatment of Unresectable Locally Advanced Pancreatic Cancer
2026-10-01 13:00 · Yahoo
NovoCure (NVCR) Stock Still Looks Cheap After Its 86% Fall
2026-09-23 17:15 · Yahoo
NovoCure (NVCR) Could Be 36% Undervalued Despite Its Recent Board Change
2026-09-23 03:20 · Yahoo
NovoCure Eyes Glioblastoma Growth, Cancer Launches and EBITDA Break-Even
2026-09-18 14:02 · Yahoo
Novocure Announces Upcoming Investor Events
2026-09-02 11:00 · Yahoo
Wall Street Analysts See a 50.86% Upside in NovoCure (NVCR): Can the Stock Really Move This High?
2026-08-28 13:55 · Yahoo
Are You Looking for a Top Momentum Pick? Why NovoCure (NVCR) is a Great Choice
2026-08-20 16:00 · Yahoo
Wall Street Analysts Think NovoCure (NVCR) Could Surge 53.68%: Read This Before Placing a Bet
2026-08-12 13:55 · Yahoo
Wall Street Analysts Believe NovoCure (NVCR) Could Rally 46.63%: Here's is How to Trade
2026-07-27 13:55 · Yahoo
Unlocking NovoCure (NVCR) International Revenues: Trends, Surprises, and Prospects
2026-07-27 13:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.